Health care

Award-winning Ojai Valley Inn Re-Opens, Debuting $5-Million Dollar Renovation Of Spa Ojai And Luxury Spa Penthouse Suites

Thursday, February 25, 2021 - 9:58pm

We are proud to debut a new, modern luxury inspired design for Spa Ojai and the Spa Penthouse Suites.

Key Points: 
  • We are proud to debut a new, modern luxury inspired design for Spa Ojai and the Spa Penthouse Suites.
  • Spa Ojai, the award-winning 31,000 square-foot spa, is at the epicenter of Ojai Valley Inn's renovation.
  • Guests at the new Spa Ojai will pass through a tranquil courtyard with a running fountain before entering the iconic spa.
  • Ojai Valley Inn also presents its newly renovated Spa Penthouse Suites that sit above Spa Ojai.

B. Braun Receives the First and Only FDA Approval for Acetaminophen Injection in Multiple Doses

Thursday, February 25, 2021 - 9:51pm

Acetaminophen Injection,manufactured by B. Braun in Irvine, California,is available in our sturdy, flexible PAB IV Bags in both 1,000 mg in 100 mL and 500 mg in 50 mL doses.

Key Points: 
  • Acetaminophen Injection,manufactured by B. Braun in Irvine, California,is available in our sturdy, flexible PAB IV Bags in both 1,000 mg in 100 mL and 500 mg in 50 mL doses.
  • B. Braun's Acetaminophen Injection is manufactured using dual-sourced Active Pharmaceutical Ingredients (API) to mitigate potential supply risks.
  • Take care when prescribing, preparing, and administering Acetaminophen Injection to avoid dosing errors which could result in accidental overdose and death.
  • B. Braun Medical is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculapand CAPS.

Dr. Reddy's Recalls Prescription Drug Blister Packages Due to Risk of Poisoning

Thursday, February 25, 2021 - 9:49pm

The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.

Key Points: 
  • The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.
  • The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.
  • Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.
  • This recall involves blister packages of prescription medications.

Merck Animal Health Completes Acquisition of Poultry Sense Limited

Thursday, February 25, 2021 - 9:30pm

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders.

Key Points: 
  • Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders.
  • In March 2019, Merck Animal Health invested in Poultry Sense Ltd., to support their development.
  • The Poultry Sense Ltd. product portfolio joins Merck Animal Health Intelligence, a newly formed specialized operating unit which takes its name from the companys strategic vision for animal health intelligence and data expertise.
  • Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck.

Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference

Thursday, February 25, 2021 - 9:01pm

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will participate in the Autoimmune/Complement panel discussion at the Cowen 41st Annual Virtual Health Care Conference on Wednesday, March 3, 2021 at 11:40am EST.

Key Points: 
  • Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will participate in the Autoimmune/Complement panel discussion at the Cowen 41st Annual Virtual Health Care Conference on Wednesday, March 3, 2021 at 11:40am EST.
  • The panel discussion will be available to live conference attendees.
  • Kezar Life Sciences is a clinical-stage biopharmaceutical company bringing novel treatments to patients with rare autoimmune diseases and cancer.
  • The company is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function to inhibit multiple drivers of disease via single, powerful targets.

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

Thursday, February 25, 2021 - 9:01pm

Vaxart made this announcement as it provided financial results for the fourth quarter and full year endedDecember 31, 2020 and provided a corporate update.

Key Points: 
  • Vaxart made this announcement as it provided financial results for the fourth quarter and full year endedDecember 31, 2020 and provided a corporate update.
  • Vaxart is also advancing S-only vaccine candidates targeted specifically against variant strains, including one targeting the South African viral strain.
  • General and administrative expenses were $5.1 million for the fourth quarter of 2020 compared to $1.3 million for the fourth quarter of 2019.
  • There were no restructuring expenses for the fourth quarter of 2020 compared to $4.9 million for the fourth quarter of 2019.

Oyster Point Pharma to Participate in the 41st Annual Cowen Healthcare Conference

Thursday, February 25, 2021 - 9:01pm

PRINCETON, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that the Company will participate virtually in the 41st Annual Cowen Healthcare Conference on Tuesday, March 2, 2021, at 11:10 a.m.

Key Points: 
  • PRINCETON, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that the Company will participate virtually in the 41st Annual Cowen Healthcare Conference on Tuesday, March 2, 2021, at 11:10 a.m.
  • To access the live webcast, please visit the Investors and News section of the Oyster Point Pharma website at https://investors.oysterpointrx.com/ .
  • Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
  • Oyster Point Pharmas lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

Dr. Jeffrey N. Doucette, Distinguished Nurse Executive, Joins Press Ganey as Chief Nursing Officer

Thursday, February 25, 2021 - 8:02pm

Press Ganey today announced that Jeffrey N. Doucette, DNP, RN, NEA-BC, FACHE, FAAN, has joined the organization as Chief Nursing Officer.

Key Points: 
  • Press Ganey today announced that Jeffrey N. Doucette, DNP, RN, NEA-BC, FACHE, FAAN, has joined the organization as Chief Nursing Officer.
  • Nursing is the backbone of acute care in U.S. health systems, said Patrick T. Ryan, Chairman and Chief Executive Officer, Press Ganey.
  • Doucette, a widely recognized and accomplished nurse leader, comes to Press Ganey with nearly 30 years of experience spent largely in leadership and executive nursing roles.
  • Doucette will join Press Ganey as Chief Nursing Officer on April 26, 2021.

United States Diabetes Drug insights Market Report 2021-2026: Clinical Trial Insight, Approved Diabetes Drugs Price & Dosage Analysis, Patent Timeline, Dosage& Formulation, Approved Drugs

Thursday, February 25, 2021 - 6:45pm

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • As per the "US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report findings related to US diabetes drug market, it is concluded that the US diabetes market will make the future of the global diabetes market more intense.
  • The US pharmaceutical market will continue to see a focus on the transformation of the diabetes market at an unprecedented rate.
  • US Insulins Based Drugs - Branded & Generic Availability, Dosage, Patent, Price & Sales Analysis

OSF HealthCare Using Data and AI to Drive an Increase in Childhood Vaccinations

Thursday, February 25, 2021 - 6:29pm

The grants leverage the resources of OSF HealthCare's Innovation Design Lab where solutions can be developed, tested, and refined for practical use.

Key Points: 
  • The grants leverage the resources of OSF HealthCare's Innovation Design Lab where solutions can be developed, tested, and refined for practical use.
  • By building on already existing data, Barrows believes the project can make a case for future funding to expand resources within communities.
  • OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health and hospice services.
  • Jump Simulation, a part of OSF Innovation , is a collaboration between University of Illinois College of Medicine at Peoria and OSF HealthCare.